| # | Drug | Count |
|---|---|---|
| 0 | FOLIC ACID | 104 |
| 1 | MISOPROSTOL | 85 |
| 2 | ZIDOVUDINE | 71 |
| 3 | ASPIRIN | 69 |
| 4 | ASPIRIN 325 MG | 69 |
| 5 | ASPIRIN 81 MG | 69 |
| 6 | ADALIMUMAB | 67 |
| 7 | DIAZEPAM | 64 |
| 8 | PREDNISOLONE | 62 |
| 9 | PREDNISOLONE ORAL | 62 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COAGULATION FACTOR XIII A-SUBUNIT (RECOMBINANT) | 1 | 0.0714 |
| 1 | DINOPROSTONE | 30 | 0.0366 |
| 2 | PRENATAL SUPPLEMENT WITH DHA | 1 | 0.0227 |
| 3 | 5-HYDROXYTRYPTOPHAN | 1 | 0.0189 |
| 4 | DOCONEXENT, NIACINAMIDE, .ALPHA.-TOCOPHEROL ACETATE, DL-, CHOLECALCIFEROL, .BETA.-CAROTENE, ASCORBIC ACID, THIAMINE MONONITRATE, RIBOFLAVIN, PYRIDOXINE HYDROCHLORIDE, CYANOCOBALAMIN, IRON, ZINC OXIDE, CUPRIC OXIDE, POTASSIUM IODIDE, MAGNESIUM OXIDE, FOLIC ACID, AND LEVOMEFOLATE CALCIUM | 1 | 0.0164 |
| 5 | NELFINAVIR MESYLATE | 24 | 0.0115 |
| 6 | CARBON DIOXIDE | 1 | 0.0087 |
| 7 | MISOPROSTOL | 85 | 0.0087 |
| 8 | AMINOPHYLLINE | 16 | 0.0079 |
| 9 | METHYLDOPA | 37 | 0.0075 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 219 |
| 1 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 122 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 122 |
| 3 | Atypical Antipsychotic [EPC] | 108 |
| 4 | Vitamin B12 [EPC] | 107 |
| 5 | Vitamin C [EPC] | 107 |
| 6 | Vitamin D [EPC] | 106 |
| 7 | Benzodiazepine [EPC] | 94 |
| 8 | Prostaglandin E1 Analog [EPC] | 86 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 84 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Oxytocic [EPC] | 21 | 0.0069 |
| 1 | Prostaglandin E1 Analog [EPC] | 86 | 0.0052 |
| 2 | beta Lactamase Inhibitor [EPC] | 12 | 0.0027 |
| 3 | Tricyclic Antidepressant [EPC] | 1 | 0.0021 |
| 4 | Opioid Antagonist [EPC] | 2 | 0.0021 |
| 5 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 41 | 0.0017 |
| 6 | Thyroid Hormone Synthesis Inhibitor [EPC] | 14 | 0.0014 |
| 7 | Nucleoside Analog Antifungal [EPC] | 2 | 0.0014 |
| 8 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 68 | 0.0014 |
| 9 | Protease Inhibitor [EPC] | 61 | 0.0014 |